SABREEN AHMED
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism GREENBELT, MD NPI 1821452749
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism MD Lilly USA, LLC All categories
General Payments — all program years on this page
$7,685.74
- Category: General Payments
- Program years: PY2019–2024
- Record count: 356
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,658.23 across 111 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,646.94 | 110 |
| Education | $11.29 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $494.00 | 22 |
| Novo Nordisk AS | $310.36 | 15 |
| Corcept Therapeutics | $304.52 | 13 |
| Insulet Corporation | $170.54 | 8 |
| CeQur Corporation | $170.11 | 1 |
| Xeris Pharmaceuticals, Inc. | $169.57 | 8 |
| SANOFI-AVENTIS U.S. LLC | $148.25 | 6 |
| Radius Health, Inc. | $124.71 | 4 |
| ABBVIE INC. | $114.94 | 5 |
| Tandem Diabetes Care, Inc. | $94.07 | 4 |
| Medtronic, Inc. | $88.75 | 3 |
| Amneal Pharmaceuticals LLC | $71.95 | 3 |
| Amgen Inc. | $59.81 | 3 |
| Alexion Pharmaceuticals, Inc. | $52.81 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $46.13 | 2 |
| DEXCOM, INC. | $38.18 | 2 |
| TOLMAR, INC. | $35.28 | 2 |
| RECORDATI_RARE_DISEASES_INC. | $32.59 | 2 |
| Sandoz Inc. | $31.80 | 1 |
| Antares Pharma, Inc. | $24.36 | 1 |
| Abbott Laboratories | $21.87 | 1 |
| Neurocrine BioSciences, Inc. | $20.58 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.61 | 1 |
| Acella Pharmaceuticals, LLC | $13.44 | 1 |
By program year
Records — PY2024 (111)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.